These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 19570520)

  • 1. A study of interactions between pharmaceutical representatives and ophthalmology trainees.
    Wang Y; Adelman RA
    Am J Ophthalmol; 2009 Oct; 148(4):619-622.e3. PubMed ID: 19570520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks.
    Hodges B
    CMAJ; 1995 Sep; 153(5):553-9. PubMed ID: 7641153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Attitudes and behaviors of psychiatry residents and psychiatrists working in training institutes towards the relationship between the pharmaceutical industry and physicians].
    Gülöksüz S; Oral ET; Ulaş H
    Turk Psikiyatri Derg; 2009; 20(3):236-42. PubMed ID: 19757223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A population-based study of the prevalence and influence of gifts to radiation oncologists from pharmaceutical companies and medical equipment manufacturers.
    Halperin EC; Hutchison P; Barrier RC
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1477-83. PubMed ID: 15275735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with physicians' reliance on pharmaceutical sales representatives.
    Anderson BL; Silverman GK; Loewenstein GF; Zinberg S; Schulkin J
    Acad Med; 2009 Aug; 84(8):994-1002. PubMed ID: 19638762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical education and the pharmaceutical industry.
    Goodman RL
    Perspect Biol Med; 2007; 50(1):32-9. PubMed ID: 17259674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between pharmaceutical representatives and doctors in training. A thematic review.
    Zipkin DA; Steinman MA
    J Gen Intern Med; 2005 Aug; 20(8):777-86. PubMed ID: 16050893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychiatric resident and faculty views on and interactions with the pharmaceutical industry.
    Misra S; Ganzini L; Keepers G
    Acad Psychiatry; 2010; 34(2):102-8. PubMed ID: 20224017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of pharmaceutical company representatives on internal medicine residency programs. A survey of residency program directors.
    Lichstein PR; Turner RC; O'Brien K
    Arch Intern Med; 1992 May; 152(5):1009-13. PubMed ID: 1580704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of a mandatory guideline that prohibit hospital doctors from accepting any form of benefits in any form from the pharmaceutical industry].
    Gundermann C; Meier-Hellmann A; Bauer M; Hartmann M
    Dtsch Med Wochenschr; 2010 May; 135(3):67-70. PubMed ID: 20077378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Teaching appropriate interactions with pharmaceutical company representatives: the impact of an innovative workshop on student attitudes.
    Wofford JL; Ohl CA
    BMC Med Educ; 2005 Feb; 5(1):5. PubMed ID: 15698480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Industry relations with emergency medicine graduate medical education programs.
    Kowalenko T; Char D; Marco C; Asher S; Raja A; Farrell S; Sokolove PE;
    Acad Emerg Med; 2009 Oct; 16(10):1025-30. PubMed ID: 19799581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of staff and residents with pharmaceutical industry: a survey of psychiatric training program policies.
    Chakrabarti A; Fleisher WP; Staley D; Calhoun L
    Ann R Coll Physicians Surg Can; 2002 Dec; 35(8 Suppl.):541-6. PubMed ID: 15015500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Policies regulating the activities of pharmaceutical representatives in residency programs.
    Brotzman GL; Mark DH
    J Fam Pract; 1992 Jan; 34(1):54-7. PubMed ID: 1728655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient awareness and concern regarding pharmaceutical manufacturer interactions with doctors.
    Edwards D; Ballantyne A
    Intern Med J; 2009 Mar; 39(3):191-6. PubMed ID: 19383067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resident surgical practice patterns for vitreoretinal surgery in ophthalmic training programs in the United States.
    Shah VA; Reddy AK; Bonham AJ; Sabates NR; Lee AG
    Ophthalmology; 2009 Apr; 116(4):783-9. PubMed ID: 19344826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attitudes and behaviors of psychiatry residents toward pharmaceutical representatives before and after an educational intervention.
    Randall ML; Rosenbaum JR; Rohrbaugh RM; Rosenheck RA
    Acad Psychiatry; 2005; 29(1):33-9. PubMed ID: 15772402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in prescribing between GPs: impact of the cooperation with pharmacists and impact of visits from pharmaceutical industry representatives.
    Muijrers PE; Grol RP; Sijbrandij J; Janknegt R; Knottnerus JA
    Fam Pract; 2005 Dec; 22(6):624-30. PubMed ID: 16055474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of marketing interactions with medical trainees' knowledge about evidence-based prescribing: results from a national survey.
    Austad KE; Avorn J; Franklin JM; Campbell EG; Kesselheim AS
    JAMA Intern Med; 2014 Aug; 174(8):1283-90. PubMed ID: 24911123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perceptions of recent ophthalmology residency graduates regarding preparation for practice.
    McDonnell PJ; Kirwan TJ; Brinton GS; Golnik KC; Melendez RF; Parke DW; Renucci A; Smith JH; Smith RE
    Ophthalmology; 2007 Feb; 114(2):387-91. PubMed ID: 17187862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.